Alka Chaubey - Sep 11, 2024 Form 4 Insider Report for Bionano Genomics, Inc. (BNGO)

Role
Chief Medical Officer
Signature
/s/ Jonathan V. Dixon, Attorney-in-Fact
Stock symbol
BNGO
Transactions as of
Sep 11, 2024
Transactions value $
-$1,476
Form type
4
Date filed
9/13/2024, 04:11 PM
Previous filing
Jun 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BNGO Common Stock Tax liability -$1.48K -3.08K -6.35% $0.48 45.3K Sep 11, 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person is reporting the withholding by the Issuer an aggregate of 3,075 shares of common stock that vested on September 11, 2024, pursuant to an RSU award granted on September 11, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award.
F2 Includes 153 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan on June 10, 2024.